New Zealand shares fell, in line with declines in the US and across Asia, amid ongoing concerns about global growth, particularly in China.
Analysts downgrading their forecasts for Australian healthcare device maker Resmed also weighed on New Zealand rival Fisher & Paykel Healthcare, one of the country's top 10 stocks.
The benchmark S&P/NZX 50 Index shed 108.14 points, or 1.2 percent, to 9,006.38. Within the index, 10 stocks rose, 33 fell and 7 were unchanged. Turnover was $127.25 million.
"Resmed has had a very poor day and that's had a big impact on Fisher & Paykel," said Grant Williamson, a director at Hamilton Hindin Greene.
Resmed shares were down more than 11 per cent on Friday and fell more than 12 per cent today after a poor December quarter report – the Australian market was closed for the Australia Day holiday yesterday.